Clinical and Genetic Characterization of 26 Tunisian Patients with Allgrove Syndrome

• Published in: Archives of medical research Vol. 47; no. 2; pp. 105 - 110
• Main Authors: Kallabi, Fakhri, Belghuith, Neila, Aloulou, Hajer, Kammoun, Thouraya, Ghorbel, Soufiane, Hajji, Mouna, Gallas, Syrine, Chemli, Jaleleddine, Chabchoub, Imen, Azzouz, Hatem, Ben Chehida, Amel, Sfaihi, Lamia, Makni, Saloua, Amouri, Ali, Keskes, Leila, Tebib, Neji, Ben Becher, Saayda, Hachicha, Monjia, Kamoun, Hassen
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2016
• Subjects: AAAS gene; Achalasia; Adrenal insufficiency; Adrenal Insufficiency - genetics; Adrenal Insufficiency - physiopathology; Alacrima; Allgrove syndrome; Amplified Fragment Length Polymorphism Analysis; Child; Child, Preschool; Esophageal Achalasia - genetics; Esophageal Achalasia - physiopathology; Female; Homozygote; Humans; Infant; Internal Medicine; Major mutation; Male; Mutation; Nerve Tissue Proteins - genetics; Nuclear Pore Complex Proteins - genetics; Tunisia; Allgrove syndrome; Achalasia; Adrenal insufficiency; Alacrima; AAAS gene; Major mutation
• ISSN: 0188-4409; 1873-5487; 1873-5487
• DOI: 10.1016/j.arcmed.2016.04.004

Allgrove syndrome is characterized by achalasia, alacrima, and adrenal insufficiency as well as being associated with progressive neurological signs. This is an autosomal recessive disorder due to mutations in the AAAS gene located on chromosome 12q13. The AAAS gene encodes a protein of 546 amino acids, ALADIN. Mutations in this genwere reported in families from North Africa and Europe. Our objective is to conduct a clinical, molecular and genetic study of 26 Tunisian patients with Allgrove syndrome. We report 26 Tunisian patients with between two and four clinical features associated with Allgrove syndrome. Blood samples were collected and isolated DNA derived from subjects was amplified. The entire sequence of the AAAS gene was analyzed by PCR and sequencing. PCR-RFLP method was performed to identify the frequent mutations found. Sequencing of the AAAS gene revealed a major homozygous mutation (c.1331+1G>A) in 25 patients and R286X mutation in one patient. The presence of a major mutation in several unrelated affected individuals suggests the presence of a founder effect in Tunisia and allows for a fast and targeted molecular diagnosis. We created an easy and rapid molecular enzymatic protocol based on PCR-RFLP using MvaI restriction enzyme that directly targets this major mutation and can be used for prenatal diagnosis and genetic counseling for Tunisian families at risk. To the best of our knowledge, this is the first major series report of Allgrove syndrome in Tunisia.